Evidence map›Paper›PMID 38123603›Full record

ArticleScientific reports2023

Towards interpretable speech biomarkers: exploring MFCCs.

Brian Tracey, Dmitri Volfson, James Glass, R'mani Haulcy, Melissa Kostrzebski, Jamie Adams, Tairmae Kangarloo, Amy Brodtmann, E Ray Dorsey, Adam Vogel

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Towards a Compositional Framework for Describing Human Phenotypes.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Article
  5. Article
  6. An End-to-End Overview of Clinical Speech AI.IEEE transactions on audio, speech, and language processing (2025) · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Optimal feature selection and model explanation for reef fish sound classification.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Article
  12. Article
  13. Article
  14. Developing digital health technologies for frontotemporal degeneration.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Brian TraceyTakeda Pharamaceuticals, Data Science Institute, Cambridge, MA, 02142, USA. brian.tracey@takeda.com.
Dmitri VolfsonTakeda Pharamaceuticals, Data Science Institute, Cambridge, MA, 02142, USA.
James GlassMassachusetts Institute of Technology, CSAIL, Cambridge, MA, 02139, USA.
R'mani HaulcyMassachusetts Institute of Technology, CSAIL, Cambridge, MA, 02139, USA.
Melissa KostrzebskiCenter for Health + Technology (CHeT), University of Rochester Medical Center, Rochester, NY, USA.
Jamie AdamsCenter for Health + Technology (CHeT), University of Rochester Medical Center, Rochester, NY, USA.
Tairmae KangarlooTakeda Pharamaceuticals, Data Science Institute, Cambridge, MA, 02142, USA.
Amy BrodtmannMonash University, Melbourne, VIC, Australia.
E Ray DorseyCenter for Health + Technology (CHeT), University of Rochester Medical Center, Rochester, NY, USA.
Adam VogelUniversity of Melbourne, Parkville, VIC, 3010, Australia.
Takeda (United States) · USUniversity of Rochester Medical Center · USMassachusetts Institute of Technology · USSynlab Czech (Czechia) · CZThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While speech biomarkers of disease have attracted increased interest in recent years, a challenge is that features derived from signal processing or machine learning approaches may lack clinical interpretability. As an example, Mel frequency cepstral coefficients (MFCCs) have been identified in several studies as a useful marker of disease, but are regarded as uninterpretable. Here we explore correlations between MFCC coefficients and more interpretable speech biomarkers. In particular we quantify the MFCC2 endpoint, which can be interpreted as a weighted ratio of low- to high-frequency energy, a concept which has been previously linked to disease-induced voice changes. By exploring MFCC2 in several datasets, we show how its sensitivity to disease can be increased by adjusting computation parameters.

Indexed as

SpeechSpeech AcousticsSignal Processing, Computer-Assisted

Identifiers

PMID38123603
PMCPMC10733367
OpenAlexW4390030622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.